Andrew T Chan Selected Research

Cyclooxygenase 2 (Cyclooxygenase-2)

1/2020	An integrated analysis of lymphocytic reaction, tumour molecular characteristics and patient survival in colorectal cancer.
1/2019	Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial.
11/2018	Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour.
10/2018	Physical Activity and Colorectal Cancer Prognosis According to Tumor-Infiltrating T Cells.
6/2017	Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.
11/2016	Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.
1/2016	MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival.
9/2015	Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality.
4/2014	Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD).
4/2014	A prospective study of macrophage inhibitory cytokine-1 (MIC-1/GDF15) and risk of colorectal cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew T Chan Research Topics

Disease

198	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 08/2005
134	Neoplasms (Cancer) 10/2022 - 06/2003
45	Carcinogenesis 04/2022 - 01/2004
43	Colonic Neoplasms (Colon Cancer) 01/2022 - 12/2008
39	Adenoma (Adenomas) 04/2022 - 06/2003
38	Microsatellite Instability 01/2022 - 08/2009
24	Inflammation (Inflammations) 10/2022 - 03/2010
21	Crohn Disease (Crohn's Disease) 01/2022 - 09/2010
18	Ulcerative Colitis 01/2022 - 03/2012
18	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2004
17	Polyps 04/2022 - 06/2003
12	Obesity 01/2022 - 09/2013
11	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 08/2013
11	Diverticulitis 01/2022 - 05/2011
11	Hepatocellular Carcinoma (Hepatoma) 10/2021 - 01/2014
10	COVID-19 01/2022 - 01/2020
9	Rectal Neoplasms (Rectal Cancer) 01/2022 - 05/2011
9	Hemorrhage 12/2020 - 03/2003
8	Infections 01/2022 - 01/2014
8	Carcinoma (Carcinomatosis) 01/2019 - 09/2014
7	Chronic Disease (Chronic Diseases) 01/2022 - 02/2014
7	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2009
6	Celiac Disease (Celiac Sprue) 01/2022 - 05/2017
5	Liver Neoplasms (Liver Cancer) 10/2022 - 09/2015
5	Pancreatic Neoplasms (Pancreatic Cancer) 10/2022 - 01/2004
5	Adenocarcinoma 01/2022 - 01/2012
5	Hypertension (High Blood Pressure) 01/2022 - 04/2013
5	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022 - 01/2014
5	Hyperinsulinism (Hyperinsulinemia) 01/2020 - 09/2017
5	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2020 - 12/2011
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2018
4	Genetic Risk Score 01/2022 - 11/2013
4	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2022 - 06/2016
4	Fibrosis (Cirrhosis) 01/2022 - 01/2014
4	Cholelithiasis 12/2021 - 08/2016
4	Insulin Resistance 12/2020 - 03/2016
4	Breast Neoplasms (Breast Cancer) 04/2020 - 04/2011
3	Gallstones (Gallstone) 10/2022 - 11/2011
3	Melanoma (Melanoma, Malignant) 01/2022 - 10/2021

Drug/Important Bio-Agent (IBA)

89	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 06/2003
42	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2005
26	Vitamin D FDA LinkGeneric 01/2022 - 09/2010
22	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2020 - 05/2007
19	Hormones (Hormone)IBA 10/2022 - 12/2006
19	NucleotidesIBA 04/2021 - 12/2008
19	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2020 - 06/2003
16	25-hydroxyvitamin DIBA 01/2021 - 01/2011
14	hydroxide ionIBA 01/2022 - 01/2011
13	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 12/2008
13	TabletsIBA 01/2022 - 01/2004
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2010
13	CalciumIBA 01/2021 - 08/2014
11	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 12/2016
10	C-Reactive ProteinIBA 01/2022 - 08/2011
10	Dietary Fiber FDA Link 01/2021 - 11/2013
9	Insulin (Novolin)FDA Link 01/2022 - 01/2009
9	Biological ProductsIBA 01/2022 - 05/2014
8	Pharmaceutical PreparationsIBA 01/2021 - 06/2006
8	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021 - 08/2007
8	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021 - 11/2014
8	C-PeptideIBA 01/2020 - 01/2009
8	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 11/2019 - 03/2010
8	EnzymesIBA 11/2019 - 08/2004
8	Oral ContraceptivesIBA 01/2019 - 08/2013
7	Glutens (Glutelin)IBA 01/2022 - 05/2017
7	ORALIT (ORS)IBA 12/2021 - 01/2020
7	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021 - 04/2013
7	Coffee FDA Link 10/2020 - 09/2015
7	Dinoprostone (PGE2)FDA Link 10/2020 - 03/2010
7	Insulin-Like PeptidesIBA 01/2020 - 01/2009
7	AdiponectinIBA 01/2018 - 09/2013
6	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 06/2012
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 10/2011
6	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2016
6	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 03/2012
6	Estrogens (Estrogen)FDA Link 01/2020 - 12/2006
6	Proton Pump InhibitorsIBA 01/2020 - 06/2006
6	CateninsIBA 01/2017 - 04/2011
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2010
5	SulfurIBA 11/2021 - 12/2017
5	Complement System Proteins (Complement)IBA 01/2021 - 06/2010
5	VitaminsIBA 01/2021 - 09/2010
5	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021 - 01/2018
5	Fatty Acid Synthases (Fatty Acid Synthase)IBA 03/2012 - 12/2008
4	SugarsIBA 01/2022 - 06/2010
4	AcidsIBA 01/2021 - 01/2020
4	Indicators and Reagents (Reagents)IBA 01/2021 - 12/2008
4	Cholecalciferol (Vitamin D3)FDA Link 01/2021 - 02/2014
4	IronIBA 01/2021 - 06/2005
4	LigandsIBA 01/2018 - 07/2015
4	ElementsIBA 11/2015 - 04/2011
4	Celecoxib (Celebrex)FDA Link 01/2012 - 06/2009
3	Genetic Markers (Genetic Marker)IBA 01/2022 - 11/2013
3	CholesterolIBA 01/2022 - 02/2013
3	VaccinesIBA 01/2022 - 01/2021

Therapy/Procedure

32	Therapeutics 01/2022 - 03/2003
19	Chemoprevention 12/2021 - 06/2003
7	Immunotherapy 01/2021 - 01/2016
4	Cholecystectomy 10/2022 - 11/2011
4	Precision Medicine 01/2020 - 01/2015